Skip to main content

Tolka AI Therapeutics

tolka.ai

Tolka AI Therapeutics develops personalized phage therapy using bacteriophages to target and eliminate antibiotic-resistant bacterial infections. This approach minimizes side effects by exclusively attacking pathogenic bacteria, addressing the urgent global health crisis of antibiotic resistance.

Traction 5/10
Oakland, United States · HQ
Founded 20237300+ followers
  • Biotechnology
Updated 2 months ago

Funding

Funding not disclosed

across 1 round

Founders

2 founders

Johan Wikström

CEO/Cofounder

Thomas Hunt

Co-Founder

Product

Features

  • Tolka AI Therapeutics develops personalized phage therapy using bacteriophages to target and eliminate antibiotic-resistant bacterial infections. This approach minimizes side effects by exclusively attacking pathogenic bacteria, addressing the urgent global health crisis of antibiotic resistance.
1
This profile is AI-generated and may contain inaccuracies.